TapewireFind a company

person · Reporting owner

WERNER ROBERT F.

Disclosed activity across 2 companies

Tapewire entity
19814
SEC CIK
0001590947

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Invitae CorpNVTA · Entity 95935Chief Accounting OfficerMay 16, 2023May 18, 2023
Twist Bioscience CorpTWST · Entity 3619Chief Accounting OfficerOctober 02, 2026October 05, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Invitae Corp

Report date May 16, 2023 · Filed May 18, 2023

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect354,748 Reported balance After 2023-05-16 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2023-05-16 · Sale · Disposed 21,559 · Balance 354,748

F1: Represents the sale of shares to cover tax withholding obligations associated with the vesting and settlement of restricted stock units.

F2: Represents a weighted average sale price. Actual sale prices ranged from $1.1993 to $1.1995 per share. The reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.

F3: Includes 5,000 shares of common stock acquired under the Invitae Corporation Employee Stock Purchase Plan on May 15, 2023 and an aggregate of 286,469 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.

Filing footnotes · ownership attribution and instrument terms

F1: Represents the sale of shares to cover tax withholding obligations associated with the vesting and settlement of restricted stock units.

F2: Represents a weighted average sale price. Actual sale prices ranged from $1.1993 to $1.1995 per share. The reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.

F3: Includes 5,000 shares of common stock acquired under the Invitae Corporation Employee Stock Purchase Plan on May 15, 2023 and an aggregate of 286,469 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.

Twist Bioscience Corp

Report date October 02, 2026 · Filed October 05, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect42,917 Reported balance After 2026-10-02 transaction · row 1
1 source row

Row 1 · 2026-10-02 · Sale · Disposed 1,482 · Balance 42,917

F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Filing footnotes · ownership attribution and instrument terms

F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
October 02, 2026 Filed Oct 5, 2026 20:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 1,482 $188.88 $279,926.09
Disclosure

SEC source: 0001214659-26-012550 · marketforms-74098.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,917

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
September 08, 2026 Filed Sep 10, 2026 20:00 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 238 $122.62 $29,184.51
Disclosure

SEC source: 0001214659-26-011555 · marketforms-73973.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,399

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
August 24, 2026 Filed Aug 25, 2026 20:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 854 $140.77 $120,220.14
Disclosure

SEC source: 0001214659-26-010827 · marketforms-73881.xml · nonDerivative · entry 2

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,637

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
August 21, 2026 Filed Aug 25, 2026 20:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 669 $139.07 $93,035.15
Disclosure

SEC source: 0001214659-26-010827 · marketforms-73881.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,491

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
August 03, 2026 Filed Aug 5, 2026 20:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 167 $85.32 $14,248.64
Disclosure

SEC source: 0001214659-26-009654 · marketforms-73660.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,160

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
June 08, 2026 Filed Jun 10, 2026 20:05 UTC Twist Bioscience Corp TWST · Entity 3619 GiftCommon Stock 500 $0.00 $0.00
Disclosure

SEC source: 0001214659-26-007315 · marketforms-73370.xml · nonDerivative · entry 3

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,327

F2 · shares: Represents a bona fide gift of shares to a charitable organization.

Read SEC document
June 08, 2026 Filed Jun 10, 2026 20:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 1,127 $69.07 $77,841.89
Disclosure

SEC source: 0001214659-26-007315 · marketforms-73370.xml · nonDerivative · entry 2

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,827

Read SEC document
June 08, 2026 Filed Jun 10, 2026 20:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 232 $69.84 $16,203.85
Disclosure

SEC source: 0001214659-26-007315 · marketforms-73370.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,954

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
May 26, 2026 Filed May 28, 2026 20:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 800 $62.48 $49,987.20
Disclosure

SEC source: 0001214659-26-006834 · marketforms-73278.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,186

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
May 21, 2026 Filed May 26, 2026 20:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 688 $53.26 $36,640.82
Disclosure

SEC source: 0001214659-26-006714 · marketforms-73246.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,986

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
May 08, 2026 Filed May 12, 2026 20:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 4,961 $56.88 $282,186.64
Disclosure

SEC source: 0001214659-26-005987 · marketforms-73147.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,674

Read SEC document
May 04, 2026 Filed May 6, 2026 20:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 164 $57.15 $9,372.40
Disclosure

SEC source: 0001214659-26-005672 · marketforms-73058.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,635

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
March 06, 2026 Filed Mar 10, 2026 20:06 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 246 $46.43 $11,420.80
Disclosure

SEC source: 0001214659-26-003067 · marketforms-72449.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,799

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
February 23, 2026 Filed Feb 25, 2026 21:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 1,693 $46.71 $79,079.69
Disclosure

SEC source: 0001214659-26-002443 · marketforms-72312.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,045

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
February 09, 2026 Filed Feb 11, 2026 21:05 UTC Twist Bioscience Corp TWST · Entity 3619 GiftCommon Stock 2,000 $0.00 $0.00
Disclosure

SEC source: 0001214659-26-001492 · marketforms-72079.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,738

F1 · shares: Represents a bona fide gift of shares to a charitable organization.

Read SEC document
February 04, 2026 Filed Feb 5, 2026 21:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 7,000 $45.65 $319,536.00
Disclosure

SEC source: 0001214659-26-001239 · marketforms-72018.xml · nonDerivative · entry 2

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,738

F2 · shares: Represents the weighted average sales price per share. The shares sold at prices ranging from $45.61 to $45.78 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Read SEC document
February 03, 2026 Filed Feb 5, 2026 21:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 175 $46.58 $8,150.80
Disclosure

SEC source: 0001214659-26-001239 · marketforms-72018.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,738

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
December 08, 2025 Filed Dec 10, 2025 21:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 230 $32.88 $7,561.94
Disclosure

SEC source: 0001214659-25-017847 · marketforms-71491.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,913

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
November 24, 2025 Filed Nov 25, 2025 21:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 822 $28.71 $23,599.21
Disclosure

SEC source: 0001214659-25-017217 · marketforms-71347.xml · nonDerivative · entry 2

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,143

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
November 21, 2025 Filed Nov 25, 2025 21:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 229 $26.50 $6,069.30
Disclosure

SEC source: 0001214659-25-017217 · marketforms-71347.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,965

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
November 18, 2025 Filed Nov 20, 2025 21:05 UTC Twist Bioscience Corp TWST · Entity 3619 GrantCommon Stock 16,324 $0.00 $0.00
Disclosure

SEC source: 0001214659-25-016997 · marketforms-71310.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,194

F1 · shares: Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of November 20, 2024 for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
November 03, 2025 Filed Nov 5, 2025 21:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 160 $32.08 $5,132.70
Disclosure

SEC source: 0001214659-25-015970 · marketforms-71204.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,870

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
October 30, 2025 Filed Nov 3, 2025 21:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 1,016 $31.44 $31,947.41
Disclosure

SEC source: 0001214659-25-015762 · marketforms-71188.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,030

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Performance Stock Units ("PSUs"). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
October 28, 2025 Filed Oct 30, 2025 20:05 UTC Twist Bioscience Corp TWST · Entity 3619 GrantCommon Stock 5,633 $0.00 $0.00
Disclosure

SEC source: 0001214659-25-015588 · marketforms-71167.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,046

F1 · shares: Represents Performance Stock Units for which target criteria was determined to have been met on October 28, 2025. 60% of the PSUs remain subject to time-based vesting and will vest on October 1, 2026, subject to continued service or acceleration of vesting as provided in the award agreement.

Read SEC document
October 06, 2025 Filed Oct 8, 2025 20:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 2,041 $32.19 $65,693.67
Disclosure

SEC source: 0001214659-25-014775 · marketforms-70960.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,413

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Performance Stock Units ("PSUs"). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
September 08, 2025 Filed Sep 10, 2025 13:11 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 235 $25.76 $6,053.60
Disclosure

SEC source: 0001214659-25-013565 · marketforms-70712.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,454

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
August 25, 2025 Filed Aug 27, 2025 20:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 853 $27.69 $23,620.42
Disclosure

SEC source: 0001214659-25-012894 · marketforms-70407.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,689

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
August 21, 2025 Filed Aug 25, 2025 20:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 238 $25.96 $6,179.43
Disclosure

SEC source: 0001214659-25-012708 · marketforms-70342.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,542

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
August 04, 2025 Filed Aug 6, 2025 20:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 186 $28.36 $5,275.70
Disclosure

SEC source: 0001214659-25-011611 · marketforms-70151.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,780

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
June 06, 2025 Filed Jun 10, 2025 20:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 225 $31.75 $7,143.75
Disclosure

SEC source: 0001214659-25-009060 · marketforms-69850.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,966

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
May 23, 2025 Filed May 28, 2025 20:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 839 $27.73 $23,263.79
Disclosure

SEC source: 0001214659-25-008474 · marketforms-69675.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,191

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
May 21, 2025 Filed May 23, 2025 20:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 242 $29.75 $7,198.77
Disclosure

SEC source: 0001214659-25-008297 · marketforms-69633.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,030

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
May 05, 2025 Filed May 7, 2025 20:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 162 $37.65 $6,099.46
Disclosure

SEC source: 0001214659-25-007100 · marketforms-69371.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,272

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
March 06, 2025 Filed Mar 10, 2025 20:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 241 $40.91 $9,860.03
Disclosure

SEC source: 0001214659-25-004110 · marketforms-68688.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,434

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
February 24, 2025 Filed Feb 25, 2025 21:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 916 $41.71 $38,209.11
Disclosure

SEC source: 0001214659-25-003433 · marketforms-68345.xml · nonDerivative · entry 2

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,675

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
February 21, 2025 Filed Feb 25, 2025 21:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 267 $44.18 $11,795.26
Disclosure

SEC source: 0001214659-25-003433 · marketforms-68345.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,591

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 21:15 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 185 $49.35 $9,130.12
Disclosure

SEC source: 0001214659-25-002010 · marketforms-67971.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,858

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
December 06, 2024 Filed Dec 10, 2024 21:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 226 $52.70 $11,911.10
Disclosure

SEC source: 0001214659-24-020170 · marketforms-67537.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,043

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
December 04, 2024 Filed Dec 6, 2024 21:05 UTC Twist Bioscience Corp TWST · Entity 3619 GrantCommon Stock 8,438 $0.00 $0.00
Disclosure

SEC source: 0001214659-24-020028 · marketforms-67499.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,269

F1 · shares: Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of November 20, 2024 for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
November 25, 2024 Filed Nov 27, 2024 21:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 789 $44.20 $34,870.64
Disclosure

SEC source: 0001214659-24-019679 · marketforms-67437.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,831

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
November 06, 2024 Filed Nov 8, 2024 21:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 1,448 $44.61 $64,588.04
Disclosure

SEC source: 0001214659-24-018615 · marketforms-67294.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,620

F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Performance Stock Units ("PSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e).

Read SEC document
November 06, 2024 Filed Nov 15, 2024 21:05 UTC Amendment Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 1,448 $44.61 $64,588.04
Disclosure

SEC source: 0001214659-24-019253 · marketforms-67369.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,620

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Performance Stock Units ("PSUs"). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
November 04, 2024 Filed Nov 6, 2024 22:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 156 $41.56 $6,483.98
Disclosure

SEC source: 0001214659-24-018497 · marketforms-67273.xml · nonDerivative · entry 2

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,068

F2 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
November 04, 2024 Filed Nov 6, 2024 22:05 UTC Twist Bioscience Corp TWST · Entity 3619 GrantCommon Stock 8,500 $0.00 $0.00
Disclosure

SEC source: 0001214659-24-018497 · marketforms-67273.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,224

F1 · shares: Represents performance stock units for which target criteria was determined to have been met on November 4, 2024. 60% of the PSUs remain subject to time-based vesting and will vest on October 1,2025, subject to continued service or acceleration of vesting as provided in the award agreement.

Read SEC document
September 06, 2024 Filed Sep 10, 2024 20:03 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 240 $39.16 $9,398.64
Disclosure

SEC source: 0001214659-24-016290 · marketforms-66950.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,724

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
August 23, 2024 Filed Aug 27, 2024 20:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 813 $43.14 $35,074.45
Disclosure

SEC source: 0001214659-24-015371 · marketforms-66847.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,964

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
August 05, 2024 Filed Aug 7, 2024 20:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 168 $39.93 $6,707.57
Disclosure

SEC source: 0001214659-24-014029 · marketforms-66738.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,777

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 20:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 242 $51.33 $12,421.62
Disclosure

SEC source: 0001214659-24-010748 · marketforms-66287.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,945

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
May 23, 2024 Filed May 28, 2024 20:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 3,361 $42.32 $142,244.24
Disclosure

SEC source: 0001214659-24-010040 · marketforms-66036.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,187

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document
May 03, 2024 Filed May 7, 2024 20:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 132 $37.13 $4,901.69
Disclosure

SEC source: 0001214659-24-008521 · marketforms-65758.xml · nonDerivative · entry 1

WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,548

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.